default author photo

Guifang Ouyang

affiliation not provided to SSRN

SCHOLARLY PAPERS

1

DOWNLOADS

17

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Measurable Residual Disease Before the Second Consolidation Guides Monitoring in Acute Promyelocytic Leukemia Treated with Retinoic Acid and Arsenic Trioxide

Number of pages: 27 Posted: 09 Jun 2025
affiliation not provided to SSRN, Shanghai Jiao Tong University (SJTU) - State Key Laboratory of Medical Genomics, affiliation not provided to SSRN, affiliation not provided to SSRN, Southern Medical University - Department of Hematology, Huazhong University of Science and Technology - Institute of Hematology, Huazhong University of Science and Technology, Zhejiang University - Department of Hematology, Fujian Medical University - Fujian Provincial Key Laboratory on Hematology, Sichuan University - Hematology Research Laboratory, Soochow University - National Clinical Research Center for Hematologic Diseases, Government of the People's Republic of China - Center for Hematology, Guangxi Medical University, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - State Key Laboratory of Experimental Hematology, affiliation not provided to SSRN, The First Affiliated Hospital of Nanjing Medical University - Department of Hematology, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Dalian University of Technology - The Second Affiliated Hospital of Dalian Medical University, affiliation not provided to SSRN, affiliation not provided to SSRN, Shandong University - Department of Hematology, Peking University - Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN and Shanghai Jiao Tong University (SJTU) - State Key Laboratory of Medical Genomics
Downloads 17 (1,481,165)

Abstract:

Loading...

Acute promyelocytic leukemia, PML::RARA fusion gene, measurable residual disease, the second consolidation therapy, relapse